EP3415651A1 — A method for manufacturing a passivated product
Assigned to Heraeus Deutschland GmbH and Co KG · Expires 2018-12-19 · 7y expired
What this patent protects
The invention generally relates to a method for manufacturing a passivated product, a passivated product, and a medical device comprising such passivated product. The passivated product comprises a raw product and a passivation coating. The raw product is made at least partially …
USPTO Abstract
The invention generally relates to a method for manufacturing a passivated product, a passivated product, and a medical device comprising such passivated product. The passivated product comprises a raw product and a passivation coating. The raw product is made at least partially of an alloy comprising Cr, Ni, Mo and Co, preferably with tightly controlled levels of impurities. The method for manufacturing the passivated product comprises a providing of a raw product and a passivating of a surface of the raw product at least partially to provide a passivated product with a passivation coating. The raw product is made at least partially of an alloy comprising the following alloy components: a) Cr in the range from about 10 to about 30 wt. %; b) Ni in the range from about 20 to about 50 wt. %; c) Mo in the range from about 2 to about 20 wt. %; d) Co in the range from about 10 to about 50 wt. %. The A1 content of the Cr, Ni, Mo and Co alloy is less than about 0.01 wt. % and each wt. % is based on the total weight of the alloy.
Drugs covered by this patent
- Arnicare Leg Cramps (COPPER) · Sebela Womens Hlth
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.